Your browser doesn't support javascript.
loading
Neuroimaging standards for research into small vessel disease-advances since 2013.
Duering, Marco; Biessels, Geert Jan; Brodtmann, Amy; Chen, Christopher; Cordonnier, Charlotte; de Leeuw, Frank-Erik; Debette, Stéphanie; Frayne, Richard; Jouvent, Eric; Rost, Natalia S; Ter Telgte, Annemieke; Al-Shahi Salman, Rustam; Backes, Walter H; Bae, Hee-Joon; Brown, Rosalind; Chabriat, Hugues; De Luca, Alberto; deCarli, Charles; Dewenter, Anna; Doubal, Fergus N; Ewers, Michael; Field, Thalia S; Ganesh, Aravind; Greenberg, Steven; Helmer, Karl G; Hilal, Saima; Jochems, Angela C C; Jokinen, Hanna; Kuijf, Hugo; Lam, Bonnie Y K; Lebenberg, Jessica; MacIntosh, Bradley J; Maillard, Pauline; Mok, Vincent C T; Pantoni, Leonardo; Rudilosso, Salvatore; Satizabal, Claudia L; Schirmer, Markus D; Schmidt, Reinhold; Smith, Colin; Staals, Julie; Thrippleton, Michael J; van Veluw, Susanne J; Vemuri, Prashanthi; Wang, Yilong; Werring, David; Zedde, Marialuisa; Akinyemi, Rufus O; Del Brutto, Oscar H; Markus, Hugh S.
Afiliação
  • Duering M; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany; Medical Image Analysis Center, University of Basel, Basel, Switzerland; Department of Biomedical Engineering, University of Basel, Basel, Switzerland. Electronic address: marco.duering@med.uni-muenche
  • Biessels GJ; Department of Neurology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Brodtmann A; Cognitive Health Initiative, Central Clinical School, Monash University, Melbourne, VIC, Australia; Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC, Australia.
  • Chen C; Department of Pharmacology, Memory Aging and Cognition Centre, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Psychological Medicine, Memory Aging and Cognition Centre, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Cordonnier C; Université de Lille, INSERM, CHU Lille, U1172-Lille Neuroscience and Cognition (LilNCog), Lille, France.
  • de Leeuw FE; Department of Neurology, Donders Center for Medical Neuroscience, Radboudumc, Nijmegen, Netherlands.
  • Debette S; Bordeaux Population Health Research Center, University of Bordeaux, INSERM, UMR 1219, Bordeaux, France; Department of Neurology, Institute for Neurodegenerative Diseases, CHU de Bordeaux, Bordeaux, France.
  • Frayne R; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada; Department of Radiology, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; Seaman Family MR Research Centre, Foothills Medical Centre, University of Calg
  • Jouvent E; AP-HP, Lariboisière Hospital, Translational Neurovascular Centre, FHU NeuroVasc, Université Paris Cité, Paris, France; Université Paris Cité, INSERM UMR 1141, NeuroDiderot, Paris, France.
  • Rost NS; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Ter Telgte A; VASCage-Research Centre on Vascular Ageing and Stroke, Innsbruck, Austria.
  • Al-Shahi Salman R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Backes WH; School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, Netherlands; School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, Netherlands; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht,
  • Bae HJ; Department of Neurology, Seoul National University College of Medicine, Seoul, South Korea; Cerebrovascular Disease Center, Seoul National University Bundang Hospital, Seongn-si, South Korea.
  • Brown R; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
  • Chabriat H; Centre Neurovasculaire Translationnel, CERVCO, INSERM U1141, FHU NeuroVasc, Université Paris Cité, Paris, France.
  • De Luca A; Image Sciences Institute, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, Netherlands.
  • deCarli C; Department of Neurology and Center for Neuroscience, University of California, Davis, CA, USA.
  • Dewenter A; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
  • Doubal FN; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Ewers M; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
  • Field TS; Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, BC, Canada; Vancouver Stroke Program, Division of Neurology, University of British Columbia, Vancouver, BC, Canada.
  • Ganesh A; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada; Mathison Centre for Mental Health Research and Education, Univ
  • Greenberg S; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Helmer KG; Department of Radiology, Massachusetts General Hospital, Boston, MA, USA; Athinoula A Martinos Center for Biomedical Imaging, Boston, MA, USA; Department of Radiology, Harvard Medical School, Boston, MA, USA.
  • Hilal S; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore.
  • Jochems ACC; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK.
  • Jokinen H; Division of Neuropsychology, HUS Neurocenter, Helsinki University Hospital, University of Helsinki, Helsinki, Finland; Department of Psychology and Logopedics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Kuijf H; Image Sciences Institute, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, Netherlands.
  • Lam BYK; Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Gerald Choa Neuroscience Institute, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Margaret
  • Lebenberg J; AP-HP, Lariboisière Hospital, Translational Neurovascular Centre, FHU NeuroVasc, Université Paris Cité, Paris, France; Université Paris Cité, INSERM UMR 1141, NeuroDiderot, Paris, France.
  • MacIntosh BJ; Sandra E Black Centre for Brain Resilience and Repair, Hurvitz Brain Sciences, Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Computational Radiology and Artificial Intelligence Unit, Radio
  • Maillard P; Department of Neurology and Center for Neuroscience, University of California, Davis, CA, USA.
  • Mok VCT; Division of Neurology, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Gerald Choa Neuroscience Institute, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Margaret
  • Pantoni L; Department of Biomedical and Clinical Science, University of Milan, Milan, Italy.
  • Rudilosso S; Comprehensive Stroke Center, Department of Neuroscience, Hospital Clinic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Satizabal CL; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Population Health Sciences, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; Department of Neurology, Bos
  • Schirmer MD; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Schmidt R; Department of Neurology, Medical University Graz, Graz, Austria.
  • Smith C; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Staals J; School for Cardiovascular Diseases, Maastricht University Medical Center, Maastricht, Netherlands; Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands.
  • Thrippleton MJ; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK; Edinburgh Imaging and Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • van Veluw SJ; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
  • Vemuri P; Mayo Clinic, Department of Radiology, Rochester, MN, USA.
  • Wang Y; Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Werring D; Stroke Research Centre, UCL Queen Square Institute of Neurology, London, UK.
  • Zedde M; Neurology Unit, Stroke Unit, Department of Neuromotor Physiology and Rehabilitation, Azienda Unità Sanitaria-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Akinyemi RO; Neuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Del Brutto OH; School of Medicine and Research Center, Universidad de Especialidades Espiritu Santo, Ecuador.
  • Markus HS; Stroke Research Group, Department of Clinical Neuroscience, University of Cambridge, Cambridge, UK.
Lancet Neurol ; 22(7): 602-618, 2023 07.
Article em En | MEDLINE | ID: mdl-37236211
ABSTRACT
Cerebral small vessel disease (SVD) is common during ageing and can present as stroke, cognitive decline, neurobehavioural symptoms, or functional impairment. SVD frequently coexists with neurodegenerative disease, and can exacerbate cognitive and other symptoms and affect activities of daily living. Standards for Reporting Vascular Changes on Neuroimaging 1 (STRIVE-1) categorised and standardised the diverse features of SVD that are visible on structural MRI. Since then, new information on these established SVD markers and novel MRI sequences and imaging features have emerged. As the effect of combined SVD imaging features becomes clearer, a key role for quantitative imaging biomarkers to determine sub-visible tissue damage, subtle abnormalities visible at high-field strength MRI, and lesion-symptom patterns, is also apparent. Together with rapidly emerging machine learning methods, these metrics can more comprehensively capture the effect of SVD on the brain than the structural MRI features alone and serve as intermediary outcomes in clinical trials and future routine practice. Using a similar approach to that adopted in STRIVE-1, we updated the guidance on neuroimaging of vascular changes in studies of ageing and neurodegeneration to create STRIVE-2.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Doenças de Pequenos Vasos Cerebrais / Disfunção Cognitiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Doenças de Pequenos Vasos Cerebrais / Disfunção Cognitiva Idioma: En Ano de publicação: 2023 Tipo de documento: Article